|
Mechanism5-HT1B receptor agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismAPOA1 stimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with The Medicines Company (Spain) SL
0 Patents (Medical) associated with The Medicines Company (Spain) SL
100 Deals associated with The Medicines Company (Spain) SL
100 Translational Medicine associated with The Medicines Company (Spain) SL